Filtered By:
Vaccination: Meningitis Vaccine

This page shows you your search results in order of relevance. This is page number 12.

Order by Relevance | Date

Total 4488 results found since Jan 2013.

A strategy to improve adherence to guideline-directed medical therapy (GDMT) and the role of the multidisciplinary team in a heart-failure programme
CONCLUSION: The multidisciplinary heart-failure programme resulted in a positive effect, in the form of improved patient care after including the clinical pharmacist and nurse specialist.PMID:37171293 | DOI:10.5830/CVJA-2022-067
Source: Cardiovascular Journal of Africa - May 12, 2023 Category: Cardiology Authors: Waleed AlHabeeb Fakhr Alayoubi Ahmed Hayajneh Anhar Ullah Fayez Elshaer Source Type: research

Costs of adult vaccination in medical settings and pharmacies: an observational study.
CONCLUSIONS: The average direct costs paid per adult vaccination were lower in pharmacies compared with physician offices and other medical settings by 16%-26% and 11%-20%, respectively. These results were mostly consistent across geographic regions and types of health plans. These data may help payers and policymakers understand the economic value of adult vaccination in different settings, especially in pharmacies. PMID: 25166292 [PubMed - in process]
Source: Herpes - August 30, 2014 Category: Infectious Diseases Authors: Singhal PK, Zhang D Tags: J Manag Care Pharm Source Type: research

Direct Medical Costs and Utilization of Health Care Services to Treat Pneumonia in the United States: An Analysis of the 2007-2011 Medical Expenditure Panel Survey.
This study aimed to assess how pneumonia incidence, health care resource utilization, costs, and hospital length of stay differ by age category in the United States. METHODS: A retrospective cross-sectional analysis of the Medical Expenditure Panel Survey database was conducted from 2007 to 2011 for patients with pneumonia. Study outcomes were pneumonia incidence, annual health care utilization, and expenditures across 5 age groups. Early trends of outcomes in the period after introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) (2011) were compared with the pre-PCV13 period (2007-2009). FINDINGS:...
Source: Clinical Therapeutics - May 19, 2015 Category: Drugs & Pharmacology Authors: Park H, Adeyemi AO, Rascati KL Tags: Clin Ther Source Type: research

Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults.
CONCLUSIONS: For persons with a single, non-IC medical condition, IPD risk was twice that for the general KPNC population. Persons with multiple, non-IC chronic conditions exhibited increased IPD risk with each additional condition. Such information may inform discussions on recommendations for adult pneumococcal immunization and prevention. PMID: 27396493 [PubMed - as supplied by publisher]
Source: Vaccine - July 6, 2016 Category: Allergy & Immunology Authors: Baxter R, Yee A, Aukes L, Snow V, Fireman B, Atkinson B, Klein NP Tags: Vaccine Source Type: research

Difference of the change of the hospitalization for pneumonia in children between Japanese secondary and tertiary medical facilities after the introduction of pneumococcal conjugate vaccine.
Abstract The aim of this study is to compare pneumonia hospitalization in children between secondary and tertiary medical facilities, hospitalizing many children without and with underlying diseases, respectively, after the introduction of pneumococcal conjugate vaccine (PCV). Our retrospective study was performed on the children who were admitted to the Department of Pediatrics at Kitakyushu General Hospital, a secondary medical facility, and at Hospital of the University of Occupational and Environment Health, Japan, a tertiary medical facility, from 2009 to 2013 for pneumonia. The variation of hospitalization r...
Source: Japanese Journal of Infectious Diseases - October 30, 2016 Category: Infectious Diseases Authors: Haro K, Ogawa M, Hoshina T, Kojiro M, Kusuhara K Tags: Jpn J Infect Dis Source Type: research